Name

Zivo Bioscience

Legal name

ZIVO Bioscience, Inc.

Website

https://zivobioscience.com

Company type

Public

Founded year

1983

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Algal Biomass and Bioactive Ingredients

NAICS

Animal Food Manufacturing (3111), Other Animal Food Manufacturing (311119), Animal Food Manufacturing (31111), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)

SIC

Medicinal Chemicals & Botanical Products (2833), Agricultural Prod-Livestock & Animal Specialties (200), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO)

akta.pro secondary industries

Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Phytogenics & Botanicals (Essential Oils, Plant Extracts) (AFADAKAF), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

Keywords

• Algal biomass ingredients
• Animal feed additives
• Bioactive compounds
• Functional food ingredients
• Nutritional supplements

Headquarters

HQ city

Troy

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Algal Biomass Product Sales: Commercial revenue from sales of dried algal biomass product (Zivolife) as a human food or food ingredient through independent distributor ZWorldwide, Inc., with initial focus on North American green powder food market. Generated $119,025 in revenue for nine months ended September 30, 2025.
2. Licensing Royalties: Revenue from licensing bioactive ingredients or molecules derived from ZIVO's algae cultures to third parties. The company has Participation Agreements providing investors 44.78% revenue share of all license fees generated.
3. Strategic Partnerships and Development Deals: Future revenue anticipated from partnerships with global animal health companies for therapeutic products, including coccidiosis treatment for poultry and bovine mastitis treatment.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

ZIVO Bioscience develops and commercializes naturally derived nutritional compounds and bioactive molecules from proprietary freshwater algae strains (Kelbsormidium Flaccidum). Its primary commercial offering is the Zivolife brand of dried algal biomass sold as a functional food ingredient for humans and as a feed additive for animal health applications targeting poultry coccidiosis and bovine mastitis. The company also isolates and licenses proprietary bioactive compounds (including a TLR4 Inhibitor molecule) for therapeutic applications in human and animal health.

Product overview

Zivo Bioscience is a U.S.-based R&D company operating in biotech and agtech sectors with a proprietary platform of optimized freshwater algae strains. The product portfolio centers on the Zivolife brand of algal biomass, which serves as the foundation for three distinct product forms: Algal Biomass (whole dried algae), Extract/Supernatant (processed bioactive extracts), and Bioactive Compounds (isolated therapeutic molecules). The company commercializes these through two primary segments: Animal Health Products (feed ingredients for poultry coccidiosis prevention and dairy cow mastitis management) and Human Nutrition Products (functional food ingredients for cholesterol management, immune support, and joint health). The platform is characterized as affordable, sustainable, adaptable, plant-based, non-GMO, and antibiotic-free.

Differentiator

Problem solved

Functional benefit

Brands

• Zivolife: Brand name for ZIVO's dried algal biomass product sold as a human food or food ingredient, with initial focus on the North American green powder food market. Product contains Vitamin A, protein, iron, important fatty acids, non-starch polysaccharides and other micronutrients.

Products and services

• Zivolife Algal Biomass Branded dried algal biomass product derived from proprietary freshwater algae strains (Kelbsormidium Flaccidum), positioned as a functional food ingredient and nutritional supplement providing a plant-based, non-GMO, antibiotic-free, sustainable source of protein, fiber, Vitamin A, iron, important fatty acids, and non-starch polysaccharides with added health benefits for human consumption.
• Animal Health Products Algae-based feed ingredients and health products for dairy cows (promoting a healthy immune response to bovine mastitis) and poultry (boosting productivity and digestive efficiency). Includes a product candidate aimed at preventing coccidiosis in broiler chickens.
• Human Nutrition Products Functional food ingredients derived from algal biomass designed to promote healthy cholesterol balance, boost immune system function, aid muscle recovery, and support joint health in humans.
• Extract/Supernatant Processed forms of the proprietary algal culture yielding bioactive extracts used in the development of health products and therapeutic applications.
• Bioactive Compounds (including TLR4 Inhibitor) Isolated and characterized biologically active molecules derived from proprietary algal cultures, including the TLR4 Inhibitor molecule, available for licensing to third parties for use in human and animal health therapeutics targeting multiple disease situations through immune modulation.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Cyanotech CorporationcoreTechnology or Integration · 6 April 2026ZIVO signed a manufacturing agreement with Cyanotech Corporation to grow, cultivate, and process its proprietary Zivolife algal biomass for commercial applications in animal health, human nutrition, and functional ingredients markets. Cyanotech operates a 96-acre production facility at NELHA on Hawaii's Big Island with over 40 years of microalgae cultivation expertise and cGMP operations with GRAS certification. The agreement provides scalable production capacity to meet anticipated global demand.
• ZWorldwide, Inc.coreChannel Partner/ Reseller/ DistributorIndependent distributor engaged by ZIVO to sell Zivolife branded product in North American green powder food market. Distributor has begun selling product with algae grown in Peru.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Alltech: Global animal nutrition and health company with algae-based feed ingredients (SP1) and a broad portfolio spanning poultry, dairy, and human nutrition. Highly comparable in animal health positioning and algae-derived ingredients.
• Cargill Animal Nutrition: One of the largest global animal feed and nutrition companies, with algae-based and functional feed additive offerings. Comparable in distribution scale, dairy and poultry customer base, and functional ingredient positioning.
• Kemin Industries: Global ingredient manufacturer focused on animal feed additives, pet food, and human nutrition. Overlaps with ZIVO's animal health (immune support, gut health) and functional food ingredients strategy.
• Roquette: Global leader in plant-based ingredients including algae-derived proteins for human nutrition and animal feed. Comparable in non-GMO, plant-based protein positioning for food, beverage, and nutraceutical markets.
• DSM-Firmenich (Animal Nutrition & Health): Global leader in animal feed additives, premixes, and nutritional ingredients. Overlaps with ZIVO's non-antibiotic performance supplements (Verax product line) and human nutrition ingredients via DSM Nutritional Products.
• Corbion: Produces algae-based ingredients (AlgaPrime DHA) for animal nutrition and human food applications. Comparable in microalgae-derived functional ingredients targeting aquaculture, poultry, and human nutrition segments.

Direct peers

• Cyanotech Corporation: Microalgae cultivation company operating the same 96-acre NELHA facility that produces ZIVO's biomass. Directly comparable in algae strain production, cGMP operations, and GRAS-certified ingredients for nutrition markets.
• Phibro Animal Health: Animal health company with a strong coccidiostat portfolio (e.g., Salinomycin, Nicarbazin). Directly comparable to ZIVO's coccidiosis candidate in target disease, customer base (poultry producers), and regulatory pathway.
• Heliae Development: Algae biotechnology company producing microalgae-based products for nutrition, wellness, and animal feed markets. Closely comparable to ZIVO in algal strain cultivation, biomass commercialization, and multi-segment go-to-market strategy.
• Huvepharma: Animal health and nutrition company with a portfolio of anticoccidial products for poultry and rumensin-related feed additives. Direct competitor in the coccidiosis prevention market that ZIVO is targeting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/zivobioscience
• Facebookfacebook.com/zivobioscience

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds15 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zivo Bioscience